Abstract
Retinyl palmitate, a widely used ingredient in cosmetic products, is promoted for its beneficial effects on the appearance of skin. Previous studies suggest that enzymes are available in skin to metabolize this ingredient during skin absorption. Esterase activity hydrolyzes retinyl palmitate to retinol (vitamin A), which is oxidized in many tissues to retinoic acid primarily by alcohol dehydrogenase. The activities of esterase and alcohol dehydrogenase were characterized in hairless guinea pig skin by using flow-through diffusion cells and radiolabeled model compounds (methyl salicylate and benzyl alcohol) previously shown to be metabolized by these enzymes. Methyl salicylate was hydrolyzed by esterase to a greater extent in viable skin than in nonviable skin. Glycine conjugation of salicylic acid and benzoic acid occurred only in viable skin. The metabolism of methyl salicylate and benzyl alcohol occurred to a greater extent in male guinea pig skin than in female guinea pig skin. The percutaneous absorption of both radiolabeled compounds was similar in viable and nonviable skin. About 30 and 18% of topically applied retinyl palmitate were absorbed from an acetone vehicle by hairless guinea pig skin and human skin, respectively. Less than 1% of the applied dose of this lipophilic compound diffused from skin into the receptor fluid. Retinol was the only detectable metabolite of retinyl palmitate in both hairless guinea pig and human skin. In human skin, 44% of the absorbed retinyl palmitate was hydrolyzed to retinol. The use of retinyl palmitate in cosmetic formulations may result in significant delivery of retinol into the skin.
Similar content being viewed by others
REFERENCES
A. Pannatier, P. Jenner, B. Testa, and J. C. Etter. The skin as a drug metabolizing organ. Drug Metab. Rev. 8:319–343 (1978).
J. Kao and M. P. Carver. Cutaneous metabolism of xenobiotics. Drug Metab. Rev. 22:363–410 (1990).
B. Idson. Vitamins in cosmetics, An update. I. Overview and vitamin A. Drug Cosmet. Ind. 146:26–92 (1990).
B. A. Gilchrest. Retinoid pharmacology and skin. In H. Mukhtar (ed.), Pharmacology of the Skin, CRC Press, Boca Raton, 1992, pp. 167–181.
T. Argyris. The distribution of succinoic dehydrogenase and non-specific esterase in mouse skin throughout the hair growth cycle. Anat. Rec. 125:105–119 (1956).
D. Nathan, A. Sakr, J. L. Lichtin, and R. L. Bronaugh. In vitro skin absorption and metabolism of benzoic acid, p-aminobenzoic acid, and benzocaine in the hairless guinea pig. Pharm. Res. 7:1147–1151 (1990).
H. Bundgaard, A. Hoelgaard, and B. Mollgaard. Leaching of hydrolytic enzymes from human skin in cutaneous permeation studies as determined with metronidazole and 5-fluorouracil prodrugs. Int. J. Pharm. 15:285–292 (1983).
D. Guzek, A. Kennedy, S. McNeill, E. Wakshull, and R. Potts. Transdermal drug transport and metabolism. I. Comparison of in vitro and in vivo results. Pharm. Res. 6:33–39 (1989).
J. S. Weiss, C. N. Ellis, J. T. Headington, T. Tincoff, T. A. Hamilton, and J. J. Voorhees. Topical tretinoin improves photoaged skin. A double blind vehicle-controlled study. J. Am. Med. Assoc. 259:527–532 (1988).
T. A. Loomis. Skin as a portal of entry for systemic effects. In V. A. Drill and P. Lazar (eds.), Current Concepts in Cutaneous Toxicity, Academic Press, New York, 1980, pp. 153–169.
M. J. Connor and M. H. Smit. The formation of all-trans-retinoic acid from all-trans-retinol in hairless mouse skin. Biochem. Pharmacol. 36:919–924 (1987).
M. A. J. Chidgey and J. Caldwell. Studies on benzyl acetate. I. Effect of dose size and vehicle on the plasma pharmacokinetics and metabolism of [methylene-14C]benzyl acetate in the rat. Food Chem. Toxicol. 24:1257–1265 (1986).
M. A. J. Chidgey, J. F. Kennedy, and J. Caldwell. Studies on benzyl acetate. III. The percutaneous absorption and disposition of [methylene-14C]benzyl acetate in the rat. Food Chem. Toxicol. 25:521–525 (1987).
S. W. Collier, N. M. Sheikh, A. Sakr, J. L. Lichtin, R. F. Stewart, and R. L. Bronaugh. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies. Toxicol. Appl. Pharmacol. 99:522–533 (1989).
A. I. Vogel. A Textbook of Practical Organic Chemistry Including Qualitative Organic Analysis, Longmans, Green, and Co., New York, 1951.
R. L. Bronaugh and R. F. Stewart. Methods for in vitro percutaneous absorption studies. III. The flow-through diffusion cell. J. Pharm. Sci. 74:64–67 (1985).
R. L. Bronaugh, R. F. Stewart, and M. Simon. Methods for in vitro percutaneous absorption studies. VII. Use of excised human skin. J. Pharm. Sci. 75:1094–1097 (1986).
R. L. Bronaugh, R. C. Wester, D. Bucks, H. I. Maibach, and R. Sarason. In vivo percutaneous absorption of fragrance ingredients in rhesus monkeys and humans. Food Chem. Toxicol. 28:369–373 (1990).
G. S. Kishore and R. K. Boutwell. Enzymatic oxidation and reduction of retinal by mouse epidermis. Biochem. Biophys. Res. Commun. 94:1381–1386 (1980).
R. S. Holmes and C. J. Masters. The developmental multiplicity and isoenzyme status of cavian esterases. Biochim. Biophys. Acta 132:379–399 (1967).
S. W. Collier, M. E. Sale, M. R. Gastonguay, R. L. Bronaugh, and S. L. Schwartz. Role of stratum corneum, viable epidermis, and saturable metabolism on percutaneous penetration of phenylazophenol. Pharm. Res. 10(Suppl):S-412 (1993).
T. J. Franz and P. A. Lehman. Systemic absorption of retinoic acid. J. Toxicol. Cutaneous Ocul. Toxicol. 8:517–524 (1989).
J. E. Storm, S. W. Collier, R. F. Stewart, and R. L. Bronaugh. Metabolism of xenobiotics during percutaneous absorption: Role of absorption rate and cutaneous enzyme activity. Fundam. Appl. Toxicol. 15:132–141 (1990).
R. L. Bronaugh. Metabolism in skin. In T. R. Gerrity and C. J. Henry (eds.), Principles of Route-to-Route Extrapolation for Risk Assessment, Elsevier Science Publishing Co., New York, 1990, pp. 185–191.
T. Gindhart, P. Bhat, and C. Silverman-Jones. Metabolites of retinol in cultured human dermal fibroblasts. Ann. N. Y. Acad. Sci. 359:393 (1981).
M. J. Connor, R. E. Ashton, and N. J. Lowe. A comparative study of the induction of epidermal hyperplasia by natural and synthetic retinoids. J. Pharm. Exp. Ther. 237:31–35 (1986).
A. K. Verma and R. K. Boutwell. Vitamin A acid (retinoic acid), a potent inhibitor of 12-O-tetradecanoyl-phorbol-13-acetate-induced ornithine decarboxylase activity in mouse epidermis. Cancer Res. 37:2196–2201 (1977).
T. R. Breitman, S. E. Selonick, and S. J. Collins. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 77:2936–2940 (1980).
S. Strickland and V. Mahdavi. The induction of differentiation in teratocarcinoma cells by retinoic acid. Cell 15:393–403 (1978).
Author information
Authors and Affiliations
Additional information
James Boehnlein: Results submitted as partial fulfillment of requirements for the M.S. in Pharmaceutical Science degree (Cosmetic Science),
Rights and permissions
About this article
Cite this article
Boehnlein, J., Sakr, A., Lichtin, J.L. et al. Characterization of Esterase and Alcohol Dehydrogenase Activity in Skin. Metabolism of Retinyl Palmitate to Retinol (Vitamin A) During Percutaneous Absorption. Pharm Res 11, 1155–1159 (1994). https://doi.org/10.1023/A:1018941016563
Issue Date:
DOI: https://doi.org/10.1023/A:1018941016563